Article
Effect of pioglitazone on the early stage of type 2 diabetic nephropathy in KK/Ta mice.
Metabolism: clinical and experimental - 1 Nov 2004
Tanimoto Mitsuo, Fan Qiuling, Gohda Tomohito, Shike Toshihide, Makita Yuichiro, Tomino Yasuhiko
Abstract excerpt
Pioglitazone (PIO) has preventive effects on impaired glucose tolerance (IGT) and urinary albumin excretion in diabetes. These effects in the early stage of diabetic nephropathy have not been fully described. Endothelial constitutive nitric oxide synthase (ecNOS) might be one of the mechanisms of glomerular hyperfiltration. The objective of the present study was to evaluate the effect of PIO, including the role...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
